Release Date: 27/08/09 13:31 Summary: Appendix 4E and Full Year Financial Report Price Sensitive: Yes Download Document 2.34MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%